After an initial focus on funding tendinopathy research, GE Healthcare and the National Basketball Association (NBA) are now turning their attention to myotendinous injuries.
GE and the NBA said they will invest up to $1.5 million over three years to support research aimed at preventing, diagnosing, and treating myotendinous injuries. Specifically, GE and the NBA are seeking research proposals to address the following questions:
- How can the effect of acute myotendinous injuries on athletic participation be reduced?
- What is the efficacy of prevention programs?
- What specific prevention, assessment, and treatment techniques are needed for different injury sites?
- What is the correlation between imaging and clinical assessment?
- Which interventions are effective for treatment?
- What are the risk factors for injury and reinjury?
Proposal entries can be submitted here and are due by September 8, 2016.
In May, GE and the NBA announced winners of its first call for proposals for tendinopathy research. More than $1.5 million will be used by six research groups from around the globe to conduct tendinopathy research over the next three years, they said.
